Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON).

Conditions:   Olfactory Neuroblastoma;   Esthesioneuroblastoma;   Neoplasm of the Nasal Cavity Intervention:   Drug: Bintrafusp alfa / M7824 Sponsor:   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials